Transdermal Drug Delivery Systems Market Analysis

Transdermal Drug Delivery System Market Analysis

With respect to type, the transdermal patches segment of the transdermal drug delivery system market is expected to garner over USD 35.5 billion by 2032. Patches are classified into matrix patches, drug-in-adhesive patches, microneedle patches, and reservoir membrane patches. The increasing prevalence of several chronic conditions, such as cardiovascular diseases, cancer, and others, will supplement the market progress.
 

Transdermal drug delivery system market from the pain management segment is poised to record a valuation of over USD 19.5 billion by 2032. Opioid patches are extensively used in pain management applications, spurring market growth. Furthermore, the increasing prevalence of cancer, resulting in the accelerated embracing of pain patches.
 

Transdermal drug delivery system market from hospitals segment is likely to emerge as a major consumer of transdermal drug delivery systems, accounting for over USD 17 billion by 2032. A large patient population undergoing treatment for a variety of disorders will accelerate product adoption across hospital settings. Furthermore, the availability of a wide range of medical services in these establishments will transform business dynamics.
 

Looking for region specific data?

 Download Free Sample

North America transdermal drug delivery system market accumulated over 46.% of revenue share in 2022 and is speculated to attain a healthy CAGR through 2032. Growing adoption of unhealthy lifestyles among individuals, such as alcohol consumption, smoking, and lack of exercise, will boost the disease rate, thereby fostering the market trends.